Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF HEPATOCYTE NUCLEAR FACTOR 4Α(HNF4Α) FOR THE TREATMENT OF HUMAN MALIGNANT SOLID TUMORS THROUGH INDUCTION-DIFFERENTIATION THERAPY
Document Type and Number:
WIPO Patent Application WO/2009/109146
Kind Code:
A1
Abstract:
Use of hepatocyte nuclear factor 4α(HNF4α) for the treatment of human malignant solid tumors through induction-differentiation therapy is provided.

Inventors:
XIE WEIFEN (CN)
YIN CHUAN (CN)
LIN YONG (CN)
CHEN YUEXIANG (CN)
ZENG XIN (CN)
Application Number:
PCT/CN2009/071590
Publication Date:
September 11, 2009
Filing Date:
April 30, 2009
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV PLA 2ND MILITARY MEDICAL (CN)
XIE WEIFEN (CN)
YIN CHUAN (CN)
LIN YONG (CN)
CHEN YUEXIANG (CN)
ZENG XIN (CN)
International Classes:
A61K38/17; A61P35/00; C12N15/11
Other References:
YIN, C. ET AL.: "Construction of recombinant adenoviruses carrying hepatocyte nuclear factor 4 a and evaluation of its effect on hepatoma gene expression.", CHIN. J. DIG., vol. 27, no. 5, 2007, pages 318 - 321
LAZAREVICH N.L. ET AL.: "Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.", HEPATOLOGY, vol. 39, no. 4, 2004, pages 1038 - 1047
SPATH G.F. ET AL.: "Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes,acting as a morphogen in dedifferentiated hepatoma cells.", J CELL BIOL, vol. 140, no. 4, 1998, pages 935 - 946
Attorney, Agent or Firm:
SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC (Xuhui, Shanghai 3, CN)
Download PDF: